CVR: 36893729
mAbSolution IVS was a Danish company of the type Iværksætterselskab based in Kgs. Lyngby, founded in 2015 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK -13,668 and a net result of DKK -13,668 compared with DKK -7,612 the year before. Equity amounted to DKK -33,920.
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringScreen owners and management against the Danish FSA's official PEP lists
As of April 11, 2019, Dres Damgaard has stepped down as director of mAbSolution IVS.
As of April 11, 2019, Jørgen Søberg Petersen has stepped down as director of mAbSolution IVS.
As of April 11, 2019, Claus Henrik Nielsen has stepped down as director of mAbSolution IVS.
MAbSolution IVS was dissolved on April 11, 2019.
MAbSolution IVS has published its annual report for 2017. Gross profit came to DKK -13,668, and the net result was DKK -13,668.
As of June 29, 2017, Jørgen Søberg Petersen is registered as director of mAbSolution IVS.
As of June 29, 2017, Jørgen Søberg Petersen is registered as chairman of mAbSolution IVS.
As of June 29, 2017, Jørgen Søberg Petersen has stepped down as chairman of mAbSolution IVS.
MAbSolution IVS has published its annual report for 2016. Gross profit came to DKK -7,600, and the net result was DKK -7,612.
As of December 7, 2016, Lars Nørgaard has stepped down as director of mAbSolution IVS.
MAbSolution IVS has published its interim report for the period May 13, 2015 – December 31, 2015.
As of May 13, 2015, Dres Damgaard is registered as director of mAbSolution IVS.
As of May 13, 2015, Lars Nørgaard is registered as director of mAbSolution IVS.
As of May 13, 2015, Claus Henrik Nielsen is registered as director of mAbSolution IVS.
MAbSolution IVS was founded on May 13, 2015.
companydata.dk